Journal Club- Heart attack survivors may be at greater risk of mental decline Dr. Nandita Mohan9 April 2022 4:30 PM ISTAccording to a study presented at the American College of Cardiology's 71st Annual Scientific Session, about 1 in 3 heart attack survivors showed...
FFR-guided PCI non-Inferior to IVUS in intermediate coronary stenosis: FLAVOUR TRIAL Dr. Kamal Kant Kohli9 April 2022 10:00 AM ISTFor stenting decisions in intermediate coronary stenosis, fractional flow reserve (FFR) guidance was non inferior to those with intravascular...
Rate of structural valve deterioration lower with TAVR than with SAVR Dr. Kamal Kant Kohli9 April 2022 9:15 AM ISTPatients who received a transcatheter supra-annular self-expanding heart valve had significantly less structural deterioration in the valve after five...
Sodium thiosulfate does not reduce heart damage after a heart attack Dr. Kamal Kant Kohli9 April 2022 9:00 AM ISTSodium thiosulfate showed no benefits for reducing injury to damaged areas of heart muscle following a heart attack, in a study presented at the...
Omecamtiv mecarbil has Little Impact on Exercise Tolerance in HF patients: METEORIC-HF Trial Dr. Kamal Kant Kohli7 April 2022 6:00 AM ISTDURHAM, N.C.- Heart failure patients taking the investigational drug omecamtiv mecarbil experience little impact on their ability to exercise compared...
Second-generation Chocolate Touch device superior to first-generation DCB for blocked arteries in leg Dr. Kamal Kant Kohli7 April 2022 6:00 AM ISTAmong patients treated for a blocked artery in the leg, second-generation paclitaxel drug-coated balloon (DCB) led to better target vessel patency and...
Intraoperative aggressive warming does not reduce major complications Dr. Kamal Kant Kohli6 April 2022 10:00 AM ISTBody temperature generally decreases during surgery, largely because anesthetic medications interfere with the body's processes for regulating...
Sotagliflozin tied to reduced risk of MACE in patients with diabetes and CKD: SCORED Trial Medha Baranwal5 April 2022 11:15 AM ISTUSA: Results from SCORED trial sheds light on the potent effect of the investigational SGLT1&2 inhibitor sotagliflozin on major cardiovascular...
Investigational Anti-Clotting Drug Asundexian cuts Bleeding Risk Among AF Patients: Lancet Dr. Kamal Kant Kohli5 April 2022 9:00 AM ISTDURHAM, N.C-A new type of anti-clotting drug Asundexian, caused fewer bleeding incidents among patients with atrial fibrillation than the commonly...
Mavacamten cuts need for invasive procedures in nearly 80% of HCM patients: VALOR-HCM Dr. Kamal Kant Kohli5 April 2022 9:00 AM ISTCleveland: Treatment with investigational mavacamten allowed patients with advanced obstructive hypertrophic cardiomyopathy (oHCM) to avoid septal...
Low salt intake reduces HF symptoms, not ED visits: SODIUM-HF trial Dr. Kamal Kant Kohli4 April 2022 11:28 AM ISTFor longtime people with heart failure have been told to lower their salt intake, but until now there has been little scientific evidence behind the...
2022 heart failure guidelines issued by ACC, AHA, HFSA Dr. Kamal Kant Kohli4 April 2022 10:30 AM ISTThe American College of Cardiology, the American Heart Association, and the Heart Failure Society of America have issued 2022 guidelines on Management...
